Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 4 institutions in 2 countries.
Vladimir-Andrey Gimenez-RiveraInfectious Diseases and Immunity in Global Health, Center for Translational Biology, The Research Institute of the McGill University Health Center, Montréal, QC H4A 3J1, Canada.ORCID 0000-0001-5055-208X
Harshita PatelInfectious Diseases and Immunity in Global Health, Center for Translational Biology, The Research Institute of the McGill University Health Center, Montréal, QC H4A 3J1, Canada.
Franck P DupuyInfectious Diseases and Immunity in Global Health, Center for Translational Biology, The Research Institute of the McGill University Health Center, Montréal, QC H4A 3J1, Canada.
Zoulfia AllakhverdiInfectious Diseases and Immunity in Global Health, Center for Translational Biology, The Research Institute of the McGill University Health Center, Montréal, QC H4A 3J1, Canada.ORCID 0000-0001-5194-2792
Charlie BouchardInfectious Diseases and Immunity in Global Health, Center for Translational Biology, The Research Institute of the McGill University Health Center, Montréal, QC H4A 3J1, Canada.ORCID 0000-0003-2430-0035
Joaquín MadrenasDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Robert BissonnetteInnovaderm Research, Montréal, QC H2X 2V1, Canada.
Ciriaco A PiccirilloDepartment of Microbiology and Immunology, McGill University, Montréal, QC H3A 2B4, Canada.
Carolyn JackInfectious Diseases and Immunity in Global Health, Center for Translational Biology, The Research Institute of the McGill University Health Center, Montréal, QC H4A 3J1, Canada.ORCID 0000-0002-0376-3324
McGill University Health Centre · CAInnovaderm (Canada) · CAMcGill University · CAUniversity of California, Los Angeles · US
Funding
Canadian Dermatology Foundation WCH Ref [412-001], CDF Team Grant for Canadian Atopic Dermatitis Cohort for Translational Immunology and Imaging (CACTI)CIHR MOP 142257
6 · The paper itself
Abstract
Atopic dermatitis (AD) is known as a skin disease; however, T cell immunopathology found in blood is associated with its severity. Skin
Indexed as
Dermatitis, AtopicAdultBiomarkersChemokinesCytokinesHumansInterleukin-13Leukocytes, MononuclearNod2 Signaling Adaptor ProteinStaphylococcus aureusBiomarkersChemokinesCytokinesInterleukin-13NOD2 protein, humanNod2 Signaling Adaptor Proteinatopic dermatitisGATA Binding Protein 3interleukin-13nucleotide-binding oligomerization domain-containing protein 2peptidoglycansignal transducer of activated T cellsStaphylococcus aureusStaphylococcus aureus enterotoxin BT helper 2 and cytotoxic type 2 T cellsthymic stromal lymphopoietinthymus and activation-related chemokinetype 2 cytokines
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
NOD2 Agonism Counter-Regulates Human Type 2 T Cell Functions in Peripheral Blood Mononuclear Cell Cultures: Implications for Atopic Dermatitis. · full record | OpenQuestion